The 2026 Q1 earnings season is in full swing, with many notable corporations nonetheless on the reporting docket within the weeks to come back.
To this point, a number of corporations have posted notably robust outcomes, together with Newmont NEM, Quanta Providers PWR, and Ametek AME, which every set quarterly data in a method or one other.
Quanta Providers Retains Climbing
Quanta Providers but once more delivered one other set of strong quarterly outcomes, with each EPS and gross sales outcomes beating Zacks Consensus Estimates. Adjusted EPS of $2.68 grew by a large 50% YoY and mirrored a 31.4% shock, whereas gross sales of $7.9 billion noticed a double-digit 26.3% YoY climb. Importantly, the backlog reached a document $48.5 billion, serving to underpin its broader enterprise momentum for a very long time to come back.
Quanta Providers raised steerage throughout many metrics, pushed by a good demand surroundings, additional including to the positivity. The broad steerage hike could be very bullish from a share momentum standpoint, a giant driver behind the inventory’s surge after it reported.
EPS revisions for its present and subsequent fiscal 12 months stay bullish, as proven under.
Picture Supply: Zacks Funding Analysis
AMETEK Experiences Report Backlog
AMETEK additionally reported a powerful set of outcomes, with gross sales of $1.9 billion rising 11% YoY and adjusted EPS of $1.97 rising by 13% from the year-ago interval. Each gadgets exceeded our consensus expectations, reflecting surprises of three.7% and 0.6% throughout earnings and gross sales, respectively.
AMETEK reported document EBITDA, with document orders rising 23% year-over-year and resulting in a document backlog as effectively. The corporate additionally raised its current-year EPS outlook due to the robust demand surroundings, with shares seeing a pleasant pop on the again of the outcomes and hovering close to all-time highs.
EPS revisions for its present and subsequent fiscal 12 months stay bullish like PWR above.
Picture Supply: Zacks Funding Analysis
Newmont Retains Producing Money
Newmont has benefited considerably from the rise in gold costs. The common gold value per oz reached $4,900 in the course of the reported interval, effectively above the $2,944 stage in the identical interval final 12 months. Free money movement of $3.1 billion all through the interval mirrored an all-time document.
Newmont’s cash-generating talents have been a notable enhance over current intervals due to the favorable backdrop. The amplified cash-generating talents result in many positives, comparable to buybacks, with NEM rising its present share repurchase program following the favorable outcomes.
The EPS outlook for its present and subsequent fiscal 12 months is probably the most bullish out of the bunch, with expectations hovering for its present and subsequent fiscal 12 months.
Picture Supply: Zacks Funding Analysis
Backside Line
The 2026 Q1 earnings cycle continues to roll alongside, with a number of corporations, specifically Newmont NEM, Quanta Providers PWR, and Ametek AME, all posting quarterly data in a method or one other.
Zacks’ Analysis Chief Names “Inventory Most More likely to Double”
Our workforce of consultants has simply launched the 5 shares with the best chance of gaining +100% or extra within the coming months. Of these 5, Director of Analysis Sheraz Mian highlights the one inventory set to climb highest.
This prime choose is a little-known satellite-based communications agency. Area is projected to develop into a trillion greenback trade, and this firm’s buyer base is rising quick. Analysts have forecasted a significant income breakout in 2025. In fact, all our elite picks aren’t winners however this one may far surpass earlier Zacks’ Shares Set to Double like Hims & Hers Well being, which shot up +209%.
Free: See Our Prime Inventory And 4 Runners Up
Quanta Providers, Inc. (PWR) : Free Inventory Evaluation Report
Newmont Company (NEM) : Free Inventory Evaluation Report
AMETEK, Inc. (AME) : Free Inventory Evaluation Report
This text initially printed on Zacks Funding Analysis (zacks.com).
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially mirror these of Nasdaq, Inc.
